After a year and a half of deliberations, a deal has been reached on a highly charged effort to expand who around the world has the right to circumvent intellectual property rules to manufacture, import and export lifesaving COVID-19 vaccines. The deal came out of some nail biting, late night negotiations this week in Geneva, at the World Trade Organization’s big ministerial meeting, the first to be in-person since 2017. But as The World’s Elana Gordon reports, both drug companies and global health advocates are disappointed with the result.
The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.
Make a gift today to help us reach our $25,000 goal and keep The World going strong. Every gift will get us one step closer.